{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:52:41Z","timestamp":1790805161906,"version":"4.1.0"},"reference-count":85,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T00:00:00Z","timestamp":1394150400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090973","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T21:28:31Z","timestamp":1394227711000},"page":"e90973","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":107,"title":["Elevated High-Density Lipoprotein Cholesterol and Age-Related Macular Degeneration: The Alienor Study"],"prefix":"10.1371","volume":"9","author":[{"given":"Audrey","family":"Cougnard-Gr\u00e9goire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-No\u00eblle","family":"Delyfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Korobelnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-B\u00e9n\u00e9dicte","family":"Rougier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Le Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Dartigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Barberger-Gateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Delcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,7]]},"reference":[{"key":"ref1","first-page":"844","article-title":"Global data on visual impairment in the year 2002","volume":"82","author":"S Resnikoff","year":"2004","journal-title":"Bull World Health Organ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archopht.124.4.529","article-title":"Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE)","volume":"124","author":"CA Augood","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.122.4.564","article-title":"Prevalence of age-related macular degeneration in the United States","volume":"122","author":"DS Friedman","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"LS Lim","year":"2012","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1167\/iovs.07-0808","article-title":"ApoB100,LDLR\u2212\/\u2212 mice exhibit reduced electroretinographic response and cholesteryl esters deposits in the retina","volume":"49","author":"L Bretillon","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/bjophthalmol-2011-300344","article-title":"The oil spill in ageing Bruch membrane","volume":"95","author":"CA Curcio","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1194\/jlr.R010538","article-title":"The ins and outs of cholesterol in the vertebrate retina","volume":"51","author":"SJ Fliesler","year":"2010","journal-title":"J Lipid Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.survophthal.2010.08.008","article-title":"Lipids and age-related macular degeneration","volume":"56","author":"AU Kishan","year":"2011","journal-title":"Surv Ophthalmol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1194\/jlr.R002238","article-title":"Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration","volume":"51","author":"CA Curcio","year":"2010","journal-title":"J Lipid Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e10329","DOI":"10.1371\/journal.pone.0010329","article-title":"Abundant lipid and protein components of drusen","volume":"5","author":"L Wang","year":"2010","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0002-9394(99)80146-9","article-title":"The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration","volume":"125","author":"EH Souied","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/aje\/kwj279","article-title":"Association between apolipoprotein E polymorphisms and age-related macular degeneration: A HuGE review and meta-analysis","volume":"164","author":"A Thakkinstian","year":"2006","journal-title":"Am J Epidemiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: far more than a lipid transport protein","volume":"1","author":"RW Mahley","year":"2000","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1167\/iovs.09-4397","article-title":"Apolipoprotein E genotype is associated with macular pigment optical density","volume":"51","author":"E Loane","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1073\/pnas.0912702107","article-title":"Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration","volume":"107","author":"W Chen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1093\/hmg\/ddi204","article-title":"Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy","volume":"14","author":"YP Conley","year":"2005","journal-title":"Hum Mol Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"16227","DOI":"10.1073\/pnas.0703933104","article-title":"A variant of mitochondrial protein LOC387715\/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration","volume":"104","author":"A Kanda","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1073\/pnas.0912019107","article-title":"Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC)","volume":"107","author":"BM Neale","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","first-page":"196","article-title":"An update on the genetics of age-related macular degeneration","volume":"13","author":"HP Scholl","year":"2007","journal-title":"Mol Vis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJMoa072618","article-title":"Complement C3 variant and the risk of age-related macular degeneration","volume":"357","author":"JR Yates","year":"2007","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1167\/iovs.10-7070","article-title":"Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration","volume":"52","author":"Y Yu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Merle BM, Maubaret C, Korobelnik JF, Delyfer MN, Rougier MB, et al. Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: the Alienor Study. PLoS One in press.","DOI":"10.1371\/journal.pone.0079848"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ophtha.2010.07.009","article-title":"Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration","volume":"117","author":"R Reynolds","year":"2010","journal-title":"Ophthalmology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"802059","DOI":"10.1155\/2011\/802059","article-title":"Lipids, lipoproteins, and age-related macular degeneration","volume":"2011","author":"KB Ebrahimi","year":"2011","journal-title":"J Lipids"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ophtha.2010.11.007","article-title":"Prevalence and risks factors of age-related macular degeneration in Oklahoma Indians: the Vision Keepers Study","volume":"118","author":"AL Butt","year":"2011","journal-title":"Ophthalmology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1076\/opep.8.4.237.1613","article-title":"Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study","volume":"8","author":"C Delcourt","year":"2001","journal-title":"Ophthalmic Epidemiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.118.3.351","article-title":"Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group","volume":"118","author":"L Hyman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0161-6420(93)31634-9","article-title":"The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study","volume":"100","author":"R Klein","year":"1993","journal-title":"Ophthalmology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/S0161-6420(97)30023-2","article-title":"The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study","volume":"104","author":"R Klein","year":"1997","journal-title":"Ophthalmology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0161-6420(03)00599-2","article-title":"The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study","volume":"110","author":"R Klein","year":"2003","journal-title":"Ophthalmology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ajo.2003.09.015","article-title":"Cholesterol and age-related macular degeneration: is there a link","volume":"137","author":"R van Leeuwen","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/archophthalmol.2010.92","article-title":"The prevalence of age-related macular degeneration and associated risk factors","volume":"128","author":"R Klein","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10238-004-0054-z","article-title":"Changes in lipid metabolism in women with age-related macular degeneration","volume":"4","author":"M Nowak","year":"2005","journal-title":"Clin Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ophtha.2006.09.033","article-title":"Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study","volume":"114","author":"JS Tan","year":"2007","journal-title":"Ophthalmology"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Cackett P, Wong TY, Aung T, Saw SM, Tay WT, et al. (2008) Smoking, cardiovascular risk factors, and age-related macular degeneration in Asians: the Singapore Malay Eye Study. Am J Ophthalmol 146: 960\u2013967 e961.","DOI":"10.1016\/j.ajo.2008.06.026"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2415-10-31","article-title":"Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis","volume":"10","author":"U Chakravarthy","year":"2010","journal-title":"BMC Ophthalmol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archopht.116.5.583","article-title":"Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study","volume":"116","author":"W Smith","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.ophtha.2003.11.010","article-title":"Risk factors for incident age-related macular degeneration: pooled findings from 3 continents","volume":"111","author":"SC Tomany","year":"2004","journal-title":"Ophthalmology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/archopht.1992.01080240041025","article-title":"Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group","volume":"110","author":"study-Goup The Eye Disease Case-Control","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Hogg RE, Woodside JV, Gilchrist SE, Graydon R, Fletcher AE, et al. (2008) Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology 115: 1046\u20131052 e1042.","DOI":"10.1016\/j.ophtha.2007.07.031"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0161-6420(02)01055-2","article-title":"Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study","volume":"109","author":"P Mitchell","year":"2002","journal-title":"Ophthalmology"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Ulas F, Balbaba M, Ozmen S, Celebi S, Dogan U (2013) Association of dehydroepiandrosterone sulfate, serum lipids, C-reactive protein and body mass index with age-related macular degeneration. Int Ophthalmol.","DOI":"10.1007\/s10792-013-9728-4"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1600-0420.2005.00474.x","article-title":"Fourteen-year incidence of age-related maculopathy and cause-specific prevalence of visual impairment and blindness in a Caucasian population: the Copenhagen City Eye Study","volume":"83","author":"H Buch","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0161-6420(86)33702-3","article-title":"Risk factors in age-related maculopathy complicated by choroidal neovascularization","volume":"93","author":"MS Blumenkranz","year":"1986","journal-title":"Ophthalmology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/ajcn\/57.3.428","article-title":"Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects","volume":"57","author":"TA Sanders","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00169100","article-title":"Serum levels of antioxidants and age-related macular degeneration","volume":"81","author":"NC Tsang","year":"1992","journal-title":"Doc Ophthalmol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archopht.117.9.1203","article-title":"Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study","volume":"117","author":"R Klein","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0161-6420(02)01565-8","article-title":"Early age-related maculopathy in the cardiovascular health study","volume":"110","author":"R Klein","year":"2003","journal-title":"Ophthalmology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s12603-010-0131-9","article-title":"Nutrition and age-related eye diseases: the ALIENOR (Antioxydants, Lipides Essentiels, Nutrition et maladies OculaiRes) Study","volume":"14(10)","author":"C Delcourt","year":"2010","journal-title":"Journal Nutr Health Aging"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000072920","article-title":"Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population","volume":"22","year":"2003","journal-title":"Neuroepidemiology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0039-6257(05)80092-X","article-title":"An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group","volume":"39","author":"AC Bird","year":"1995","journal-title":"Surv Ophthalmol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ophtha.2005.12.013","article-title":"Prevalence of age-related macular degeneration in 4 racial\/ethnic groups in the multi-ethnic study of atherosclerosis","volume":"113","author":"R Klein","year":"2006","journal-title":"Ophthalmology"},{"key":"ref53","unstructured":"Centre National Hospitalier d\u2019Information sur le M\u00e9dicament(CNHIM). Theriaque Web site. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.theriaque.org\" xlink:type=\"simple\">https:\/\/www.theriaque.org<\/ext-link>. Accessed February 1, 2013."},{"key":"ref54","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/humu.20288","article-title":"Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD)","volume":"27","author":"PN Baird","year":"2006","journal-title":"Hum Mutat"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Delcourt C, Delyfer MN, Rougier MB, Amouyel P, Colin J, et al. (2011) Associations of Complement Factor H and smoking with early age-related macular degeneration: the ALIENOR study. Invest Ophthalmol Vis Sci.","DOI":"10.1167\/iovs.10-6235"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.297.16.1793","article-title":"Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration","volume":"297","author":"JM Seddon","year":"2007","journal-title":"JAMA"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2307\/2531734","article-title":"Models for longitudinal data: a generalized estimating equation approach","volume":"44","author":"SL Zeger","year":"1988","journal-title":"Biometrics"},{"key":"ref58","first-page":"98","article-title":"Correlation between Serum Lipids and Age-related Macular Degeneration: A Case-Control Study","volume":"13","author":"MH Davari","year":"2012","journal-title":"J Res Health Sci"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1517\/14656566.3.7.803","article-title":"Could statins prevent age-related macular degeneration","volume":"3","author":"NF Hall","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"340","DOI":"10.5694\/j.1326-5377.2001.tb143604.x","article-title":"Cholesterol-lowering medications reduce the risk of age-related maculopathy progression","volume":"175","author":"CA McCarty","year":"2001","journal-title":"Med J Aust"},{"key":"ref61","first-page":"615","article-title":"Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration","volume":"137","author":"HL Wilson","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bjo.87.9.1121","article-title":"The association between statin use and age related maculopathy","volume":"87","author":"G McGwin Jr","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"ref63","first-page":"199","article-title":"The relationship of statin use to the development of age-related macular degeneration","volume":"46","author":"E Friedman","year":"2005","journal-title":"IOVS"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ophtha.2004.10.027","article-title":"The use of cholesterol-lowering medications and age-related macular degeneration","volume":"112","author":"G McGwin Jr","year":"2005","journal-title":"Ophthalmology"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ajo.2006.11.021","article-title":"Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study","volume":"143","author":"JS Tan","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"ref66","first-page":"50","article-title":"[Use of statins as a form of protection against age-related macular degeneration (AMD)]","volume":"110","author":"M Drobek-Slowik","year":"2008","journal-title":"Klin Oczna"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/archopht.119.9.1354","article-title":"Medication use and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study","volume":"119","author":"R Klein","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/archopht.121.8.1151","article-title":"Relation of statin use to the 5-year incidence and progression of age-related maculopathy","volume":"121","author":"R Klein","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/bmj.326.7383.255","article-title":"Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement","volume":"326","author":"R van Leeuwen","year":"2003","journal-title":"BMJ"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/bjo.2004.064477","article-title":"A case control study of age related macular degeneration and use of statins","volume":"89","author":"L Smeeth","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archopht.124.1.33","article-title":"3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study","volume":"124","author":"G McGwin Jr","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2007.02.047","article-title":"Statin use and the five-year incidence and progression of age-related macular degeneration","volume":"144","author":"R Klein","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/02713680902741670","article-title":"Statins do not decrease the risk for wet age-related macular degeneration","volume":"34","author":"N Kaiserman","year":"2009","journal-title":"Curr Eye Res"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.ophtha.2009.06.055","article-title":"Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial","volume":"116","author":"MG Maguire","year":"2009","journal-title":"Ophthalmology"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/09286586.2011.560746","article-title":"Statin use and the risk of age related macular degeneration in a large health organization in Israel","volume":"18","author":"V Shalev","year":"2011","journal-title":"Ophthalmic Epidemiol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/157488608783333952","article-title":"Use of statins and angiotensin converting enzyme inhibitors (ACE-Is) and the risk of age-related macular degeneration: nested case-control study","volume":"3","author":"M Etminan","year":"2008","journal-title":"Curr Drug Saf"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/IAE.0b013e318276e0cf","article-title":"Role of statins in the development and progression of age-related macular degeneration","volume":"33","author":"BL VanderBeek","year":"2013","journal-title":"Retina"},{"key":"ref78","first-page":"865","article-title":"The controversy over the association between statins use and progression of age-related macular degeneration: a mini review","volume":"4","author":"V Peponis","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"ref79","first-page":"CD006927","article-title":"Statins for age-related macular degeneration","volume":"3","author":"P Gehlbach","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref80","first-page":"274629","article-title":"Friend Turns Foe: Transformation of Anti-Inflammatory HDL to Proinflammatory HDL during Acute-Phase Response","volume":"2011","author":"HB G","year":"2011","journal-title":"Cholesterol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/1874091X01206010078","article-title":"High Density Lipoprotein and it\u2019s Dysfunction","volume":"6","author":"E Eren","year":"2012","journal-title":"Open Biochem J"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1161\/ATVBAHA.112.300133","article-title":"High-density lipoprotein function, dysfunction, and reverse cholesterol transport","volume":"32","author":"EA Fisher","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng.291","article-title":"Common variants at 30 loci contribute to polygenic dyslipidemia","volume":"41","author":"S Kathiresan","year":"2009","journal-title":"Nat Genet"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"TM Teslovich","year":"2010","journal-title":"Nature"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0161-6420(95)31034-2","article-title":"The prevalence of age-related maculopathy in the Rotterdam Study","volume":"102","author":"JR Vingerling","year":"1995","journal-title":"Ophthalmology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T01:19:37Z","timestamp":1689038377000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090973"}},"subtitle":[],"editor":[{"given":"Demetrios","family":"Vavvas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,7]]},"references-count":85,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090973","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,7]]}}}